Prevalence and long-term course of macro-aspartate aminotransferase in children

Maria Caropreso1, Giuliana Fortunato, Selvaggia Lenta

  • 1Department of Pediatrics, University of Naples Federico II, Naples, Italy.

The Journal of Pediatrics
|December 30, 2008
PubMed

Insights

Macro-aspartate aminotransferase (macro-AST) was found in over a third of children with elevated AST. This condition appears benign in childhood, with macro-AST often persisting long-term.

Area of Science:

  • Clinical Biochemistry
  • Pediatric Gastroenterology

Background:

  • Elevated aspartate aminotransferase (AST) levels in children can be a diagnostic challenge.
  • Macro-aspartate aminotransferase (macro-AST), a complex of AST with other molecules, can cause persistent AST elevation.
  • Understanding the prevalence and clinical significance of macro-AST in pediatric populations is crucial.

Purpose of the Study:

  • To determine the prevalence of macro-AST in children with isolated elevated AST.
  • To investigate the association of macro-AST with clinical conditions.
  • To evaluate the long-term clinical and laboratory course of macro-AST in children.

Main Methods:

  • Screening of 44 children with isolated elevated serum AST for macro-AST using electrophoresis and % polyethylene glycol (PEG) precipitable activity (PPA).
  • Clinical and laboratory follow-up for up to 16 years.
  • Analysis of AST levels and macro-AST persistence over time.

Main Results:

  • Macro-AST was identified in 38.6% of the children studied.
  • Children with macro-AST had significantly higher AST values compared to those without.
  • Macro-AST persisted in most positive cases over long-term follow-up, while AST levels normalized in macro-AST-negative children.

Conclusions:

  • Macro-AST is a common finding in children with isolated AST elevation and appears to be a benign phenomenon.
  • Established %PPA thresholds can serve as an effective screening tool for macro-AST.
  • Electrophoresis is recommended for confirmation and in cases with intermediate %PPA results.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.